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Dysferlin plays a critical role in the Ca2+-dependent
repair of microlesions that occur in themuscle sarco-
lemma. Of the seven C2 domains in dysferlin, only
C2A is reported to bind both Ca2+ and phospholipid,
thus acting as a key sensor in membrane repair. Dys-
ferlin C2A exists as two isoforms, the ‘‘canonical’’
C2A and C2A variant 1 (C2Av1). Interestingly, these
isoforms have markedly different responses to Ca2+
and phospholipid. Structural and thermodynamic an-
alyses are consistent with the canonical C2A domain
as a Ca2+-dependent, phospholipid-binding domain,
whereas C2Av1 would likely be Ca2+-independent
under physiological conditions. Additionally, both
isoforms display remarkably low free energies of sta-
bility, indicative of a highly flexible structure. The in-
verted ligand preference and flexibility for both C2A
isoforms suggest the capability for both constitutive
and Ca2+-regulated effector interactions, an activity
that would be essential in its role as a mediator of
membrane repair.
INTRODUCTION
Muscle tissue generates mechanical force. The stress placed on
the sarcolemmal membrane as a result of this force introduces
microlesions in the muscle cell membrane, which without in vivo
repair mechanisms would result in cell death (McNeil, 2002).
Repair of membrane lesions depends on the activity of dysferlin,
a multiple C2 domain-containing protein proposed to play a role
in the vesicle fusion associated with membrane repair (Bansal
et al., 2003). Mutations within the 8.5 kb dysferlin (DYSF) gene
can result in recessive forms of muscular dystrophy, such as
limb-girdle muscular dystrophy (LGMD), Mioshi myopathy
(MM), or distal anterior compartment myopathy (DMAT) (Illa
et al., 2001). Currently, approximately 500 unique human muta-
tions have been cataloged in the DYSF gene (den Dunnen,
2012). These include point mutations within the predicted folded
domains, the interdomain linkers, and premature truncations of
the primary sequence (den Dunnen, 2012).104 Structure 22, 104–115, January 7, 2014 ª2014 Elsevier Ltd All rigThe physiological mechanism of action of dysferlin is not yet
understood; however, several hypotheses have been proposed.
Dysferlin-deficient mice accumulate subsarcolemmal vacuoles
at the surface ofmuscle cell membranes; consequently, dysferlin
has been implicated in vesicle fusion at the site of injury (Bansal
et al., 2003; Selcen et al., 2001). Dysferlin could also play a
synaptotagmin-like role to interact with SNARE proteins that
mediate the fusion of patching vesicles (Evesson et al., 2010;
Miyake and McNeil, 1995), or dysferlin may act as a scaffold
for other fusion-related proteins, such as MG53 (Cai et al.,
2009a, 2009b; Matsuda et al., 2012; McCann et al., 2012). Dys-
ferlin localizes to the t-tubule network (Ampong et al., 2005;
Klinge et al., 2010) and may therefore be involved in vesicle traf-
ficking to the sarcolemma through its interactions with tubulin
(Azakir et al., 2010). In addition, it may be instrumental in signal
transduction pathways related to membrane repair (Covian-
Nares et al., 2010). The most prevalent view is that dysferlin
mediates the Ca2+-dependent fusion of intracellular vesicles
with microtears in the sarcolemma through the concerted inter-
action of its seven C2 domains with Ca2+ and phospholipid
(McNeil et al., 2000).
Dysferlin is a 237 kDa protein composed of seven, intermit-
tently spaced C2 domains (C2A–C2G) (Figure 1A). There are 14
isoforms of human dysferlin that are derived from differential
splicing events at exons 1, 5a, 17, and 40a (Pramono et al.,
2009). Most of these alternative exons encode interdomain linker
sequences; however, C2A is the only folded domain in dysferlin
with two alternative primary sequences (Pramono et al., 2006).
Exon 1 in the dysferlin gene (DYSF) encodes the first 29 amino
acids of the ‘‘canonical’’ dysferlin C2A domain, which is currently
themost thoroughly characterized (Figure 1B); whereas, exon 1a
encodes the first 30 amino acids of the dysferlin C2A variant 1
domain (C2Av1). Approximately 23% of the dysferlin transcripts
in skeletal muscle incorporate exon 1a, but no physiological
function has been demonstrated for this isoform (Pramono
et al., 2006). To determine the differences between the canonical
C2A and the C2Av1 isoforms, we merged biophysical studies
with in vitro approaches to gain structure-function insight into
the role of these two domains in membrane repair.
We solved the X-ray structure of each C2A domain to high res-
olution, characterized the Ca2+ and phospholipid binding activ-
ities of each, and established their subcellular localization in
cultured muscle cells. We show that the canonical C2A domainhts reserved
Figure 1. Overall Schematic of Dysferlin
Domain Structure, Exon Structure, and
C2A Primary/Secondary Sequence
(A) Overall modular organization of the full-length
dysferlin protein. The spacers between C2 do-
mains have been scaled according to the pre-
dicted distances between C2 domains. Yellow
spheres correspond to predicted Ca2+-binding C2
domains in dysferlin based on conserved residues
in the primary sequence alignments. The dotted
red line corresponds to the FerA/B and DysN/
DysC domains.
(B) Schematic of the partial exon structure of
dysferlin C2A.
(C) Primary sequence alignment of C2A variant 1
versus the canonical C2A domain of dysferlin. The
arrows above the sequence correspond to resi-
dues that possess b strand secondary structure,
whereas the helical cartoon corresponds to resi-
dues with a-helical secondary structure.
Structure
Analysis of Dysferlin C2A/C2Av1of dysferlin possesses two classes of Ca2+ binding sites, each
with distinct biophysical roles. The first class is a single, high-
affinity Ca2+ binding site that stabilizes the domain. The second
class is a set of low-affinity Ca2+ binding sites that mediate the
interactions between the C2A domain and the negatively
charged phospholipid membrane, consistent with its role as
a Ca2+-dependent phospholipid binding domain. The C2Av1
does not bind Ca2+, but it may become more sensitive to Ca2+
in the presence of phospholipids. Further, both C2A domains
exhibit some of the lowest free energies of stability yet measured
in a folded protein, suggesting remarkable conformational plas-
ticity (Dunker et al., 2001; Gauer et al., 2012). This flexibility
allows the C2A domains of dysferlin to explore different subsets
of conformations for maximal ligand and effector binding poten-
tial (Gauer et al., 2012). In addition, because both isoforms of
dysferlin are coexpressed in the same tissues, and both localize
to the plasma membrane, the Ca2+-independent C2Av1 could
likely act in concert with the Ca2+-dependent C2A-dysferlin at
the plasma membrane to regulate and fine-tune the membrane
repair response.
RESULTS
Canonical Dysferlin C2A Is a Type 2 C2 Domain
Human dysferlin C2A (residues 1–125) crystallized in 2.8 M
sodium formate as two stacked trimers in the asymmetric unit
(Table 1). We solved the X-ray structure of these crystals to
2.0 A˚ resolution (Figure 2A) by molecular replacement, using
the nuclear magnetic resonance (NMR) structure of the C2A
domain of myoferlin (2DMH) as the search model. The canonical
C2A domain is a b sandwich fold of eight b strands connected by
a type 2 C2 domain topology (Figure 2B). Three loops at the apex
of the domain form the divalent cation binding pocket. Loops 1Structure 22, 104–115, January 7, 2014and 3 typically possess amino acids that
interact with phospholipids. Both the my-
oferlin (2DMH) (Yokoyama et al., 2000)
and the otoferlin C2A domains (3L9B)
(Helfmann et al., 2011) share a similar ar-chitecture. Primary sequence alignment between dysferlin C2A
and myoferlin C2A revealed that the two proteins share 66%
sequence similarity between their C2A domains. The root-
mean-square deviation (rmsd) between the C2A domains of my-
oferlin (1DMH) and dysferlin is 0.83 A˚ over all Ca atoms. Otoferlin
C2A is structurally similar to dysferlin C2A; however, its vestigial
Ca2+ binding loop 1 is significantly shorter than the homologous
loop in either myoferlin or dysferlin (Helfmann et al., 2011).
The Variant of C2A Shows Fundamental Structural
Differences in the Ca2+-Binding Pocket
The primary sequence of C2Av1 (residues 1–126) possesses
more basic amino acids than does the canonical C2A domain
(Figure 1C). At pH 7.4, the calculated isoelectric point (pI) for
the canonical C2A domain is 7.66, whereas the calculated pI
for C2Av1 is 10.4 (Anandakrishnan et al., 2012). The increase in
pI is due to five additional basic residues encoded by the alter-
nate exon. To understand the impact of the alternate residues
on the C2 structure, we solved the X-ray crystal structure of
C2Av1 to 1.8 A˚ resolution using a monomer of our dysferlin
C2A structure (4IHB) as the search model (Table 1). The C2Av1
domain crystallized as a single trimer in the asymmetric unit un-
der low ionic strength conditions (Figure 3A), whereas the canon-
ical C2A crystal structure crystallized as two stacked trimers
under high salt conditions. The overall structure of C2Av1 is
similar to that of the canonical C2A domain as the rmsd between
both isoforms is 0.493 A˚ over all Ca atoms (Figure 3B). The
resulting primary sequence substitution affects b strand 1, loop
1, and b strand 2. Therefore, despite the substitution of two b
strands and one loop, the overall fold of the C2A domain has
been conserved. The most significant changes occur in Loop
1, which typically possess the residues for Ca2+ and lipid binding
in C2 domains. Upon solving the crystal structure of the C2Av1ª2014 Elsevier Ltd All rights reserved 105
Table 1. Crystallographic Parameters
Canonical Dysferlin C2A Dysferlin C2Av1
Data Collection
Space group I 1 2 1 P3121
a,b,c (A˚) 102.4, 70.7,118.3 71.2, 71.2, 137.5
a,b,g () 90, 113.4, 90 90,90,120
Resolution (A˚) 50–2.04 50–1.8
Rsym (%) 7.3 (41.5) 7.5 (53.5)
I/sI 11.1 (3.1) 26 (3.7)
Completeness (%) 99.3 (99.5) 95.7 (98.9)
Redundancy 3.6 (3.6) 6.6 (7.0)
Refinement
Resolution (A˚) 33.9–2.04 30–1.8
No. reflections 48,842 36,605
Rworking/Rfree (%) 20.0/24.0 19.2/21.5
No. Atoms
Protein 5,959 5,515
Formate ions (FMT) 41 –
Ca2+ 1 –
Water 261 612
Average B Factors (A˚2)
Protein 49.27 26.8
Solvent 48.0 34.6
FMT/Ca2+ 43.5/65.9 /
Rmsds
Bond lengths (A˚) 0.008 0.024
Bond angles () 1.347 1.816
Structure
Analysis of Dysferlin C2A/C2Av1isoform, it became clear that the additional arginine residues in
loop 1 form salt bridges to each of the remaining Ca2+ binding
residues in the C2 domain (Figure 3C). Arg-20 forms a salt bridge
interaction with Glu-75; Arg-21 coordinates with Asp-23; and
Arg-81 coordinates with Asp-73. Interestingly, Asn-72 contrib-
utes to Ca2+ binding in the canonical C2A domain, but it is
sterically blocked by the aliphatic chain of Arg-21. Therefore,
we predict C2Av1 to have reduced potential for Ca2+ binding
relative to that of the canonical C2A domain.
Ca2+ and Phospholipid Binding of the Canonical C2A
versus C2Av1
In the crystal structure of the canonical C2A domain, one of the
six molecules in the asymmetric unit coordinated a single diva-
lent cation (Figures 2A and 2C). The residues that coordinate
this cation have an average cation:ligand distance of 2.6 A˚;
therefore, we modeled and refined it as a calcium ion (Cates
et al., 2002). The position of this cation and its coordinating res-
idues superimposewith the X-ray structure of the La3+-boundC2
domain of phospholipase C-d1 (Essen et al., 1997) (Figure 2C).
Based on this structural similarity, the site of an additional cation
binding site in dysferlin C2A can be inferred from the ‘‘II’’ position
in the phospholipase C-d1 C2 domain. Asp-18, Ile-19, Asp-21,
Asn-40, Asp-71, His-72, and Glu-73 of dysferlin C2A could
contribute side-chain or main-chain oxygen atoms to coordinate
two divalent cations in dysferlin C2A. The phospholipase C-d1106 Structure 22, 104–115, January 7, 2014 ª2014 Elsevier Ltd All rigC2 domain has the potential for a third ion (Essen et al., 1997);
however, two of the homologous residues in dysferlin C2A likely
preclude Ca2+ binding at that site. Glu-73 would collide with a
third divalent cation at the ‘‘III’’ position (Figure 2C), and Arg-79
would not contribute to productive Ca2+ binding.
To quantify the ligand binding properties of the two isoforms,
we measured the Ca2+ binding affinity of the canonical C2A
and the C2Av1 using isothermal titration calorimetry (ITC). The
isotherm of the canonical C2A domain exhibited an abrupt
‘‘hook’’ at lower ligand to protein ratios and an exponential
curve at the higher end of the isotherm. This overall shape indi-
cates two distinct classes of Ca2+ binding sites (Figure 4A;
also see Figure S1 available online). Assuming two classes of
independent binding sites, our model predicts n = 1 high-affinity
binding site with nanomolar binding affinity (KD) (Table 2) and n =
4.8 low-affinity binding sites with micromolar affinity (Table 2).
Accurate fitting of the high-affinity portion of the isotherm is
limited by the extreme steepness in that part of the curve
(Zubriene et al., 2009) and by the amount of residual Ca2+ that
can be removed from the system by Chelex-100, resulting in
the large error associated with these values. In addition, the
measured value for the high-affinity binding site is at the lower
range for standard ITC (KD 1–10 nM) (Leavitt and Freire,
2001; Zubriene et al., 2009), so accurate measurements of
Ca2+ binding affinity would be difficult. A competitive binding
assay to better characterize the high-affinity sites was attemp-
ted using Mg2+ as a competing ion; however, no significant
Mg2+ binding could be measured (Figure S2). Interestingly,
under similar experimental conditions, we do not observe
Ca2+ binding by C2Av1 (Figure 4A).
In other C2 domains, the presence of acidic phospholipid
often enhances Ca2+ binding (Li et al., 2006; Radhakrishnan
et al., 2009). For the canonical dysferlin C2A domain, the Ca2+
binding affinity for the lower-affinity class of sites increased
from 53 to 15.5 mM in the presence of phospholipid PC:PS
(60:40) and fit to n = 2.1 Ca2+ sites (Figure 4C; Table 2). Although
C2Av1 has no substantial Ca2+ binding affinity in solution, it does
show a robust avidity for negatively charged phospholipids
(Figures 4B and S3). In addition, after this domain binds phos-
pholipids, a single high-affinity Ca2+ binding site is uncovered
(Figure 4C; Table 2). Once this membrane-induced high-affinity
Ca2+ binding site is occupied, the avidity of the C2Av1 for mem-
brane decreases significantly (Figure 4D).
Protein Stability on the Order of Thermal Energy ‘‘kT’’
Conformational flexibility has been suggested as a mechanism
for binding a wide variety of effectors in the C2A domain of syn-
aptotagmin (Gauer et al., 2012). If the dysferlin C2A domains
share this property, it should be reflected by an increase in the
calculated stability (DG of unfolding) of the domain upon ligand
binding, as monitored by changes in the enthalpy (DH) and the
transitionmidpoint (TM) determined by differential scanning calo-
rimetry (DSC). In the case of the canonical dysferlin C2A domain,
the TM in the presence of 5 mM EGTA was 42.2
C (Table 2; Fig-
ure S4). In the presence of saturating Ca2+, the TM increased to
54.9C. The net increase in TM of C2A in the presence of satu-
rating Ca2+ is consistent with ligand-dependent stabilization of
the canonical C2A domain. With the C2Av1, we measured a TM
of 55C with or without Ca2+, suggesting that Ca2+ does nothts reserved
Figure 2. Crystal Structure of the Canonical
Dysferlin C2A Domain
(A) Ribbon diagram of the stacked trimeric
arrangement of the asymmetric unit of human
dysferlin C2A. The green sphere is a single Ca2+
coordinated to one of the six domains in
the asymmetric unit. Noncrystallographic 3-fold
symmetry operators are represented as triangles.
(B) An isolated canonical C2A domain is shown in
green.
(C) Ca2+ binding sites in dysferlin C2A. The green
sticks correspond to the dysferlin C2A structure.
The green sphere corresponds to the high-affinity
Ca2+ found in the crystal structure (chain E, 4IHB).
The yellow sticks correspond to the three La3+
described in the phospholipase C-d1 C2 domain
(1DJG, residues 628–756) (Essen et al., 1997). The
residue numbers refer to the corresponding amino
acids in the human dysferlin sequence.
Structure
Analysis of Dysferlin C2A/C2Av1bind or impart stability to C2Av1 in solution. This is consistent
with our ITC results, which show no significant Ca2+ binding by
C2Av1 in solution (Figure 4A).
The free energy of stability (DG of unfolding) is a measure
of the interactions that maintain the overall fold of a protein.
Consequently, the DG of unfolding acts as an energy barrier
that must be overcome to unfold the protein. When this barrier
is low, the intermolecular interactions stabilizing the protein are
small enough to allow the protein to sample multiple subconfor-
mations. For most proteins, the DG of unfolding ranges from
5 to 15 kcal/mol (Pace, 1990); however, the stability of the
C2A isoforms of dysferlin was found to be markedly lower
than these typical values. In the absence of ligands, the DG
was measured to be 0.17 kcal/mol and 0.33 kcal/mol for the
canonical C2A and C2Av1, respectively (Figure 5A; Table 2;
Figure S4). These low free energies are indicative of a sig-
nificant population of partially or completely unfolded state
(Uversky, 2002). Assuming that the two-state model of unfold-
ing is valid in this case (Supplemental Information; Tables
S1–S3), at 37C, 57% of the canonical C2A and 63% of theStructure 22, 104–115, January 7, 2014C2Av1 molecules would exist in a highly
ordered/folded state in the absence of
ligand. For comparison, in a protein solu-
tion with a DG of 5 kcal/mol, 99% of all
the protein molecules are in the folded
state at this temperature.
The canonical C2A domain of dysfer-
lin possesses a single high-affinity
Ca2+ binding site that would likely be
completely occupied at the resting
muscle Ca2+ concentrations of 50 nM
(Berchtold et al., 2000). To test the effects
of this high-affinity site on the stability of
the domain, we measured the stability of
the canonical C2A domain in the pres-
ence of 1 mMCa2+. Under these subsatu-
rating conditions, we observed only a
slight increase in the TM but a marked in-
crease in themeasured enthalpy (Table 2;Figure S4). The increase in the enthalpy in the presence of 1 mM
Ca2+ correlates with an increase in the stability (Figure 5B;
Table 2; Figure S4) and a concomitant decrease in the plasticity
of the domain. Therefore, we propose that the nanomolar Ca2+
binding site in the canonical dysferlin C2A domain predominantly
serves a structural role by stabilizing the domain at resting
cellular Ca2+ concentrations. In the presence of saturating
Ca2+, we measure a further increase in DG for the canonical
C2A domain to 0.66 kcal/mol, which was also accompanied by
a 12.7C increase in the TM (Table 2; Figure S4). Interestingly,
DG for the C2Av1 domain also increased in the presence of
Ca2+ (DG = 0.73 kcal/mol), albeit not to the same extent as
that measured in the canonical C2A domain. This small increase
in the stability of the C2Av1 domain in the presence of Ca2+
shown in the absence of Ca2+ binding is likely due to the higher
ionic strength of the solution restricting the flexibility of the
population of partially folded domains, though it could also imply
athermal binding.
The canonical C2A domain showed no significant increase in
stability in the presence of phospholipids alone (PC:PS 60:40,ª2014 Elsevier Ltd All rights reserved 107
Figure 3. Crystal Structure of the Human
Dysferlin C2A Variant 1 Domain
(A) Asymmetric unit of C2Av1.
(B) Single C2Av1 domain.
(C) Cation binding pocket of dysferlin C2Av1. The
variant residues are shown in blue.
Structure
Analysis of Dysferlin C2A/C2Av1large unilamellar vesicles) (0.18 kcal/mol) (Figure 5C; Table 2;
Figure S4). However, with Ca2+ and phospholipid, the DG for
the canonical C2A increased to 1.03 kcal/mol, consistent with
Ca2+-dependent phospholipid binding activity. In contrast, we
measured a marked increase in DG for C2Av1 in the presence
of phospholipid (1.08 kcal/mol) (Figure 5C; Table 2; Figure S4)
but a decrease in the presence of Ca2+ and phospholipid
(DG = 0.45 kcal/mol) (Figure 5D; Table 2; Figure S4). Regard-
less, both the canonical C2A and C2Av1, regardless of ligation
state, have exceptionally weak stabilizing interactions that sum
to no more than twice thermal energy (kT or 600 cal/mol at
ambient temperature), yet will still be in exchange with a signifi-
cant population of partially structured conformations. The com-
plete thermodynamic analyses of these domains are presented
in the Supplemental Information.
Electrostatic Surface Potential Defines Membrane
Interactions of the C2A Domains of Dysferlin
For well-characterized C2 domains, interaction with membrane
occurs via an electrostatic switch (Figures 6E and 6F) and hy-
drophobic anchors located on loops 1 and 3. Because these
loops also shape the Ca2+ binding pocket of the C2 domains108 Structure 22, 104–115, January 7, 2014 ª2014 Elsevier Ltd All rights reservedof synaptotagmin, Ca2+ and lipid binding
are effectively linked. Both isoforms of
dysferlin C2A possess a single methio-
nine residue (Met-75) on loop 3, but
they lack a hydrophobic residue on
loop 1. In addition, the surfaces of both
the canonical C2A and C2Av1 possess
a prominent positive electrostatic feature
that could attract the domain to nega-
tively charged phospholipids (Figure 6).
This feature is accentuated upon occu-
pancy of the mM affinity Ca2+ binding
sites (Figure 6B), consistent with the
Ca2+-dependent phospholipid binding
activity observed in other C2 domains.
A strongly basic electrostatic surface
appears to be a constitutive property
of C2Av1 (Figure 6C) and is consistent
with the ability of the C2Av1 to interact
with the membrane in the absence
of Ca2+.
C2A and C2Av1 Colocalize in
Cultured C2C12 Cells
In human muscle tissue, the ratio of ca-
nonical C2A to C2Av1 dysferlin transcript
is roughly 4:1 (Pramono et al., 2006);
however, the relative amount of eachisoform varies among other tissues (Figure S5). To determine
the differences between the plasma membrane localization of
full-length canonical C2A-dysferlin or C2Av1-dysferlin, we moni-
tored the localization of transfected EGFP-dysferlin fusion con-
structs bearing each isoform in cultured C2C12 myoblasts by
confocal microscopy. The efficiency of plasma membrane tar-
geting of each isoform was assessed by flow cytometry. Trans-
fectedmyoblasts were incubated with antibodies that selectively
recognize an extracellular epitope but are unable to cross the
plasma membrane. Labeling experiments were performed at
<10C, to prevent vesicular trafficking and endocytosis of the
surface-bound antibodies. These surface-binding experiments
(immunohistochemistry [IHC] and fluorescence-activated cell
sorting [FACs]) showed that both constructs bear a similar
intrinsic capacity to target the plasma membrane (Figure 7A).
Confocal microscopy shows similar levels of surface-expressed
dysferlin and similar subcellular localization of both isoforms as
revealed by the autofluorescence of the EGFP fusion protein
(Figure 7A). Flow cytometry verified similar levels of plasma
membrane expression for both C2A and C2Av1 isoforms by
quantifying levels of surface-labeled dysferlin, relative to total
levels of EGFP fluorescence (Figure 7B).
Figure 4. Ligand Binding Profiles for the
Canonical Dysferlin C2A and the C2Av1
Domains
The canonical construct is shown above as black
triangles, whereas the C2Av1 construct is shown
as blue circles. The fits of the canonical C2A data
are shown as a gray line, whereas the fits of
the C2Av1 data are shown as a dashed red line.
All heats were normalized to the concentration of
protein in the sample cell at each injection.
(A) Titration of 102 mM dysferlin C2A and the
titration of 103 mM C2Av1 with Ca2+.
(B) Titration of 50 mMdysferlin C2A and the titration
of 56 mM C2Av1 with LUVs made of a 60:40
mixture of POPC:POPS.
(C) Titration of 80 mMdysferlin C2A and the titration
of 108 mM dysferlin C2Av1 with Ca2+ in the pres-
ence of 5 mM total lipid composed of LUVs made
of a 60:40 mixture of POPC:POPS.
(D) Titration of 47 mMdysferlin C2A and the titration
of 90 mM dysferlin C2Av1 with LUVs made of a
60:40 mixture of POPC:POPS in the presence of
2 mM Ca2+.
Structure
Analysis of Dysferlin C2A/C2Av1DISCUSSION
The ferlin proteins have been implicated in various cellular pro-
cesses ranging from vesicle fusion tomembrane repair. Dysferlin
is the onlymember of this family that has been specifically adapt-
ed for Ca2+-dependent membrane repair (Lek et al., 2010). Over
time, the first C2 domain (C2A) became the sole Ca2+-dependent
phospholipid binding domain in the dysferlin protein (Therrien
et al., 2009); however, the alternative exon 1a exists within the
DYSF gene, which encodes a C2A domain that utilizes Ca2+
differently. Alternate first exons in the DYSF gene are evolu-
tionary preserved within the genomes of fish and mammals
(data not shown), indicative of an essential role in the physiolog-
ical function of dysferlin in eukaryotic cells. Further, the genomic
sequences of otoferlin and myoferlin do not possess a homolog
to exon 1a, despite their evolutionary relatedness with dysferlin.
Although myoferlin is structurally similar to dysferlin and is coex-
pressed in the same tissues, overexpression of myoferlin does
not fully rescue the dysferlin null phenotype (Lostal et al.,
2012). These findings highlight the biological significance of the
dysferlin protein and the importance of examining the role of
C2Av1 in membrane repair. To lay the groundwork for under-
standing the function of mixed canonical C2A-dysferlin and
C2Av1-dysferlin proteins in the cell, we conducted extensive
biophysical and thermodynamic analysis of both domains.
The crystal structure of dysferlin C2A together with structural
homology to other cation-bound C2 domains argues for two
discrete Ca2+ binding sites within the divalent cation-binding
pocket of the canonical dysferlin C2A. However, our ITC binding
model fits to two independent classes of binding sites instead of
two discrete binding sites. The first class corresponds to a singleStructure 22, 104–115, January 7, 2014calcium ion with nanomolar affinity and
likely plays a purely structural role in the
domain. The other class of sites in the
canonical C2A domain of dysferlin binds
with micromolar affinity and correspondsto an apparent five calcium ion binding model. In total, our ITC
analysis fits to six binding sites. This is clearly inconsistent with
total number of cations that can be accommodated in the diva-
lent cation binding pocket of most other C2 domains. To recon-
cile this perceived discrepancy, we measured the energetic
parameters that are required to maintain the fold of these C2A
domains by DSC. Our DSC analysis suggests that both dysferlin
C2A domains have remarkably low stability. Further, such low
stability is indicative of a significant population of highly flexible
structures in the unfolded or partially unfolded state, where
multiple conformational states are sampled (Gauer et al., 2012;
Uversky, 2002). Given this flexibility, the Ca2+ binding loops
may be in a receptive conformation to coordinate calcium ions,
whereas the remainder of the domain may be able to form bind-
ing pockets that appear as structurally ill-defined sites (Figure 8).
Indeed, the number of Ca2+ sites decreases upon membrane
binding (Table 2), implying that as the number of conformations
in the ensemble decreases, some of the accessory low-affinity
Ca2+ binding sites are no longer represented.
Unlike the Ca2+-dependent canonical C2A domain, the alter-
native loop 1 sequence in C2Av1 effectively mimics the Ca2+-
bound canonical C2A dysferlin molecule in the cytosol. Indeed,
the guanidino groups of Arg-20 and Arg-21 in the C2Av1 crystal
structure may approximate the positions of the two calcium ions
in the canonical C2A domain. Although the C2Av1 domain does
not bind Ca2+ in solution, it is nonetheless affected by Ca2+.
C2Av1 could possess a single high-affinity Ca2+ binding site
that is exposed upon binding membrane. Our ITC measure-
ments do not support Ca2+ binding by C2Av1 in the absence
of membrane (Figure 4A; Table 2), but the thermodynamic
parameters from the DSC experiments do show stabilization ofª2014 Elsevier Ltd All rights reserved 109
Table 2. Summary of ITC Ligand Binding Data and Summary of DSC Ligand Binding Data
ITC Results
Ca2+ Only Ca2+ in Lipid Background
C2A C2Av1 C2A C2Av1
n1 0.9 ± 0.1 – 1.9 ± 0.2 0.5 ± 0.04
Kd1 (mM) 0.006 ± 0.008 – 0.0010 ± 0.003 0.0020 ± 0.0006
K1 (mM)
1 170 ± 240 – 1000 ± 300 500 ± 100
DH1 (kcal/mol) 0.43 ± 0.15 – 4.1 ± 0.4 0.1 ± 0.03
TDS1 (kcal/mol) 10.4 ± 0.7 – 7.8 ± 0.2 11.5 ± 0.1
DG1 (kcal/mol) 10.9 ± 0.8 – 11.9 ± 0.2 11.4 ± 0.2
n2 4.8 ± 0.2 – 2.1 + 0.4 0.1 ± 0.05
Kd2 (mM) 53.2 ± 0.1 – 15.5 ± 2.1 375 ± 22
K2 (mM)
1 0.019 ± 0.004 – 0.064 ± 0.017 0.0027 ± 0.002
DH2 (kcal/mol) 4.6 ± 0.2 – 2.2 ± 0.5 2.59 ± 0.09
TDS2 (kcal/mol) 1.02 ± 0.06 – 4.2 ± 0.4 7.11 ± 0.05
DG2 (kcal/mol) 5.6 ± 0.1 – 6.3 ± 0.8 4.51 ± 0.03
DSC Results
No ligand (+ EGTA)
TM (
C) DH (kcal/mol) TDS (kcal/mol) DG (kcal/mol) % Folded
Dys C2A 42.2 ± 0.60 12.6 ± 0.8 12.4 ± 0.9 0.17 ± 0.02 57
Dys C2Av1 55.6 ± 0.01 18.3 ± 0.04 17.9 ± 0.04 0.33 ± 0.03 63
1mM Ca2+
Dys C2A 44.7 ± 0.8 27.8 ± 0.5 27.2 ± 0.5 0.58 ± 0.04 72
Dys C2Av1 – – – – –
5mM Ca2+
Dys C2A 54.9 ± 0.30 20.9 ± 0.30 20.3 ± 0.30 0.66 ± 0.010 75
Dys C2Av1 55.7 ± 0.80 25.4 ± 0.30 24. 7 ± 0.30 0.73 ± 0.02 77
Phospholipid
Dys C2A 44.0 ± 1.00 11. 0 ± 1.00 11.0 ± 1.00 0.18 ± 0.04 58
Dys C2Av1 51.0 ± 0.40 34.4 ± 0.70 33.2 ± 0.60 1.08 ± 0.008 86
Phospholipid + Ca2+
Dys C2A 55.0 ± 1.00 27.4 ± 0.30 26.4 ± 0.40 1.03 ± 0.03 84
Dys C2Av1 52.2 ± 0.01 19.9 ± 0.20 19.5 ± 0.20 0.45 ± 0.008 68
Thermodynamic parameters for Ca2+ binding of the canonical dysferlin C2A and C2Av1 constructs in both the presence and absence of 60:40 POPC:
POPS lipid vesicles. Fit assuming two sets of independent binding sites. Summary of the DSC results. DCP is 0.97 ± 0.01 and 1.32 ± 0.02 for the
canonical and variant C2A domain, respectively. % folded is the fraction of C2A domain folded under the stated conditions. All errors reported repre-
sent the 95% confidence interval of the fits.
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Analysis of Dysferlin C2A/C2Av1C2Av1 by Ca2+ interaction (Table 2; Figure S4). Because Ca2+
binding by C2Av1 was not demonstrated by ITC, we cannot
explicitly state that this stabilization is solely due to binding.
Instead, this increase may be due to several processes, such
as athermal binding or a restriction of conformational flexibility
due to a change in the conditions of the solution. Therefore,
the canonical C2A domain utilizes increasing cytoplasmic Ca2+
to initiate membrane binding, while the C2Av1 isoform may use
high levels of Ca2+ to alter its conformational ensemble to
interact with membrane less efficiently (Figure 5D).
Membrane Binding Model for Dysferlin C2A Isoforms
For other C2 domains, membrane binding involves electrostatic
localization followed by membrane anchoring (Murray and
Honig, 2002). Comparison of the electrostatic surface potential
of the twoC2A domains of dysferlin suggests the initial phospho-
lipid binding response is predominantly electrostatic in nature,110 Structure 22, 104–115, January 7, 2014 ª2014 Elsevier Ltd All rigdue to the preponderance of basic charge distributed across
their molecular surfaces (Figure 6). This seems to be the case
for both the canonical and C2Av1 domains of dysferlin as they
show a clear preference for acidic phospholipids but have no
avidity for uncharged, PC-only membranes (Figure S3). It is
therefore likely that the canonical C2A domain of dysferlin relies
on a Ca2+-dependent electrostatic switch mechanism. In
contrast, C2Av1 cannot independently bind Ca2+; therefore,
the membrane-binding model for C2Av1 must be different.
One possibility is that C2Av1 associates with membrane analo-
gous to the nPKC-ε C2 domain. The nPKC-ε domain also pos-
sesses membrane-binding properties that are not dependent
on the surrounding Ca2+ concentration (Ochoa et al., 2001).
Loop 1 of the nPKC-ε C2 domain possesses two arginine resi-
dues that are predicted to snorkel into the membrane, whereas
loop 3 anchors to the membrane via hydrophobic interactions
from Ile-89 and Tyr-91 (Ochoa et al., 2001). In dysferlin C2Av1,hts reserved
Figure 5. Free Energy Diagrams of Dysferlin C2A Domains
In the absence of Ca2+ (A), Ca2+ (B), phospholipid (C), and phospholipid and
Ca2+ (D). At any point along the curve, the native and denatured states of the
C2A domains exist at varying ratios. As the temperature changes so does the
ratio between the two states.Where the curve crosses 0 kcal/mol on the y axis,
the populations of protein in the native and denatured states are equal to one
another; below this, the protein is found predominantly in the denatured state,
and above this, the protein is predominantly found in the native state. The open
circles on each curve represent the temperature over which the protein
denatured.
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Analysis of Dysferlin C2A/C2Av1Met-77 on loop 3 could penetrate and anchor the domain to the
acyl chains of the phospholipid, whereas the three basic resi-
dues on loop 1 (Lys-18, Arg-19, and Arg-20) could snorkel and
associate with the acidic head group of the phospholipid (Schow
et al., 2011).
Sensors of Membrane Damage
One of the most remarkable aspects of our thermodynamic
analysis has been the exceptionally low stability of these
domains. Although we are not suggesting that the C2A domains
of dysferlin are intrinsically disordered, they do share character-
istics that classify them as weakly stable, but folded, protein
domains (Fisher and Stultz, 2011). Low stability is likely a key
feature of these domains that accentuates dysferlins ability to
mediate lipid fusion or to interact with other molecules that
assist in the membrane repair process. A similar conclusion
was drawn concerning synaptotagmin function (Gauer et al.,
2012) and other membrane-interacting domains (Halskau
et al., 2009). The weak energies that we measure in the C2A
domains of dysferlin also predict that pathogenic mutations
would be expected to perturb the ensemble distribution,
thereby altering the functional, biological response in a nonpre-
dictable manner. This also suggests that experiments to test the
properties of dysferlin C2A using mutagenesis should be inter-
preted carefully.
The inverted ligand preference, ligand binding complexity, and
thermodynamic properties that we measure for both isoforms
of the dysferlin C2A suggest the potential for diverse effector
interactions that range from constitutive membrane interaction
to Ca2+-regulated interaction. The canonical C2A domain in
dysferlin binds at least two calcium ions, each with a specific
function (Figure 8). The high-affinity site measured in the canon-Structure 22, 10ical C2A domain would be fully occupied at the resting, intracel-
lular Ca2+ concentration of 50 nM. Therefore, this site likely
stabilizes the domain, whereas the lower affinity Ca2+ binding
site (KD = 53 mM) mediates phospholipid binding and environ-
mental sensitivity. At basal Ca2+ concentrations, C2Av1-dysfer-
lin mimics Ca2+-bound canonical C2A and would dominate the
initial interactions with the membrane and possibly the inter-
actions with the C2A-dependent repair proteins. However, at
high intracellular Ca2+ concentrations following membrane dam-
age, both the canonical and variant isoforms of C2A-dysferlin
could be recruited to the membrane, to assemble the repair
complex rapidly. The mixed population of canonical and
variant C2A isoforms that are present within cells could allow
for graded-responses to membrane damage depending on the
Ca2+ concentration and the ratio of C2A-dysferlin to C2Av1-
dysferlin in any given cell type, enabling the cell to respond
more effectively to membrane damage under a wide range of
conditions.
EXPERIMENTAL PROCEDURES
Expression Constructs
The gene encoding the human dysferlin canonical C2A domain was obtained
from Dr. Elizabeth McNally (Davis et al., 2002). The DNA sequence
corresponding to human dysferlin C2A (residues 1–125) was cloned into
pGEX-4T. The gene encoding human dysferlin C2Av1 (residues 1–126) was
subcloned into a pET28a expression vector with an N-terminal His6-MBP
tag and a tobacco etch virus protease cleavage site. Cys2Ala was introduced,
as we predicted that it should be exposed to solvent and may interfere with
purification and crystallization.
Both the canonical and the C2Av1 constructs were expressed in BL21
(DE3) cells. Ten liters of cells were grown in a BioFlo 3000 fermentor at
30C in Terrific Broth to an optical density (OD600) of 1.3. The temperature
of the cell cultures was then lowered to 18C, and heterologous protein
expression was induced by adding 400 mM isopropyl b-D-1 thiogalactopyra-
noside. The cells were grown for an additional 12 hr and harvested by centri-
fugation. The cell pellets were frozen in liquid nitrogen and stored at 80C
until needed.
Crystallization and Data Collection
The canonical C2A domain was crystallized in 2.8 M sodium formate and
0.1 M sodium acetate (pH 5.5) using the hanging droplet method with puri-
fied protein at a stock concentration of 10 mg/ml. Crystals were grown at
7C. Typically, the crystals reached full size overnight. C2Av1 was crystal-
lized in 16% PEG 20000 and 0.1 M sodium citrate (pH 6.2). Crystals were
grown using the hanging drop methods with purified protein at 10 mg/ml.
Crystals were also grown at 7C. Typically, the crystals reached full size
within 3 days.
The crystals of both C2 domains were captured into nylon loops and frozen
in liquid N2. Initial data sets were collected on a Rigaku ScreenMachine. Sub-
sequent data sets were collected at SLAC beamline 7-1. The wavelength of the
final data sets was 0.9796 A˚, and the data were collected at 90 K. X-ray data
were processed with imosflm (Battye et al., 2011), and the data were scaled
using SCALA as a part of the CCP4 package (Winn et al., 2011). A summary
of the crystal statistics are presented in Table 1.
Isothermal Titration Calorimetry
Isothermal titration calorimetry experiments to determine the binding of Ca2+
and POPC:POPS containing lipid LUVs to dysferlin were performed on a TA
Instruments Nano ITC at 15C. Both the Ca2+ and lipid titrant solutions were
prepared in buffer consisting of 20 mM HEPES and 100 mM KCl at pH 7.5
that was passed through Bio-Rad 100 Chelex resin to remove cation impurities
and filtered using a 0.2 mm Nalgene PES disposable filter unit. The protein
was buffer exchanged into the same 20 mM HEPES and 100 mM KCl buffer
using Bio-Rad 10DG disposable chromatography columns. The Ca2+ stock4–115, January 7, 2014 ª2014 Elsevier Ltd All rights reserved 111
Figure 6. Electrostatic Surface Potential of
Dysferlin C2 Domains
(A and B) The canonical C2A domain with (A) a
single Ca2+ and canonical C2A with two Ca2+ (B).
(C and D) Dysferlin C2Av1 with no ligand (C) and a
single Ca2+ (D). Solvent-accessible surface is
colored by the calculated electrostatic potential
and displayed at ± 3 kT/e. Calcium ions are high-
lighted by a circular outline.
(E and F) The electrostatic surface potential rep-
resentation of synaptotagmin 1 C2A with and
without (E) and with (F) saturating Ca2+ (1byn) is
shown for comparison (Shao et al., 1998). Calcium
ions are highlighted by a circular outline.
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Analysis of Dysferlin C2A/C2Av1concentrations used in the experiments were verified using a BAPTA fluores-
cence assay (Invitrogen/Molecular Probes). The titrant lipid concentration was
verified by phosphate assay according to standard protocols (Kingsley and
Feigenson, 1981). Heats of dilution were conducted with replicate titrations
in the absence of protein and subtracted from the corresponding data sets
in order to determine the binding parameters.
Differential Scanning Calorimetry Methods
Differential scanning calorimetry (DSC) experiments were performed on a
NanoDSC (TA Instruments) at a scan rate of 1C/min. Representative raw
DSC data are presented in Figure S4. DSC methods are described in the Sup-
plemental Experimental Procedures. To see if measured enthalpies varied with
concentration or scan rate, both constructs were denatured over a range of
concentrations and scan rates (Table S3). All scans were conducted in
Chelex-ed 20 mM MOPS and 100 mM KCl (pH 7.5). Scans performed in the
absence of Ca2+ contained 5 mM EGTA. All scans in the presence of Ca2+
were done at a concentration of 5 mM to ensure near saturated conditions.
The concentration of the Ca2+ stock solution used for all scans was verified
using both a calcium ion selective electrode (ThermoScientific) and a BAPTA
chelating assay (Invitrogen/Molecular Probes). Scans carried out in the pres-
ence of lipid contained LUVs composed of a 60:40 mixture of POPC:POPS
and 2 mM Ca2+.112 Structure 22, 104–115, January 7, 2014 ª2014 Elsevier Ltd All rights reservedCellular Localization of C2A versus C2Av1
Antibodies and Cell Culture
C2C12 myoblasts were cultured and transfected
as previously described (Evesson et al., 2010).
Data presented are from transfected C2C12; iden-
tical results were obtained in transfected HEK293
(data not shown). Antibodies to the following
proteins were used: mouse anti-Myc (1:200 for
IHC, Santa Cruz Biotechnology), rabbit anti-Flag
(1:5,000 for IHC, Abcam ab1162), mouse anti-His
(1:300 flow cytometry), goat anti-rabbitAlexa647
(1:200 for IHC and flow), and donkey anti-
mouseAlexa555 (1:200 for IHC) (Invitrogen).
Surface Labeling of Dysferlin for Confocal
Microscopy
Live C2C12 transfected with EGFP-FLC2A
DysferlinFLAG or EGFP-FLC2Av1DysferlinMycHis
were inverted onto a droplet of primary antibody
diluted in blocking reagent (Hank’s balanced salt
solution [HBSS] containing 20% FBS) on a paraf-
ilm-covered glass plate resting on ice for 90 min.
Cells were washed in PBS, fixed in 3%paraformal-
dehyde in PBS, and incubated in blocking buffer
for 15 min. Cells were then incubated with Alexa-
conjugated secondary antibodies diluted in block
for 60 min, washed in PBS, and mounted onto
Fluorsave-mounting reagent (Merck). Confocal
microscopy was performed using a Leica SP5scanning confocal microscope with a 633 HCX Plan Apo oil immersion lens
(1.4). Images (10243 1024) were captured without subtraction of glow-under.
Background was subtracted postcapture using Adobe Photoshop software,
through a single adjustment of the levels histogram.
Flow Cytometry
C2C12 transfected with EGFP-FLC2ADysferlinMycHis or EGFP-FLC2Av1
DysferlinMycHis were trypsinized on the morning of the experiment, replated
into the same dish, and incubated for 3 hr at 37C to recover and re-express
surface dysferlin. Cells were then dissociated from the plate by incubation for
5 min at 37C with Versene (0.48 mM EDTA4Na in PBS). Cells were gently tritu-
rated from the plate in HBSS + 10% FCS, transferred to a falcon tube, and pel-
leted by centrifugation at 3003g for 2min. The 3 hr replating step assistedwith
cell dissociation, yielding >90% live cells as assessed by propidium iodide (PI)
exclusion.Cellswere resuspended in cold PBScontaining 1%BSAwithmouse
anti-His (1:200), incubated for 90 min at 4C, washed with PBS, pelleted as
before, and then resuspended in buffer containing donkey anti-mouseAlexa647
for 1 hr at 4C. Cells were thenwashed twice and resuspended in PBS contain-
ing PI (5 mg/ml). Flow cytometry was performed using a Becton Dickenson
LSRII cytometer equipped with FACSDiva software (BDBiosciences). Postac-
quisition analysis was performed using FlowJo software (Tree Star). Gating for
live cells was performed based on PI exclusion (data not shown); gating for
transfected and untransfected cells is shown in Figure 7B.
Figure 7. Full-Length Dysferlin Proteins
Bearing Alternately Spliced Canonical C2A
or C2Av1 Show Similar Intrinsic Capacity
to Target the Plasma Membrane
(A) Representative confocal images showing
surface-expressed EGFP-FLC2ADysferlinMycHis or
EGFP-FLC2Av1DysferlinMycHis. Transfected C2C12
myoblasts were incubated with mouse anti-His to
selectively label the extracellular His epitope.
Labeling was performed on live cells at <10C
to prevent endosomal internalization of surface-
bound antibody. Cells were then washed, fixed,
and labeled with goat anti-mouse555. Scale bar
10 mM.
(B) Flow cytometry quantifies similar levels of
surface-expressed EGFP-FLC2ADysferlinMycHis or
EGFP-FLC2Av1DysferlinMycHis. Transfected C2C12
myoblasts were dissociated from the culture
dish and labeled as live cells at <10C with
mouse anti-His followed by an anti-mousealexa647
secondary antibody. Live cells were gated
based on impermeability to propidium iodide
(data not shown). (Left panel) Shows increasing
levels of surface-labeled anti-Hisalexa647 (x axis)
is proportional to the levels of EGFP auto-
fluorescence (y axis). Gates for transfected
(Tfd) and untransfected (Un) cells are shown;
very highly transfected cells often show signs
of toxicity and were excluded from analysis.
(Middle panel) Histogram showing similar
normal distributions of surface bound anti-
mousealexa647 in populations of transfected
cells expressing FLC2A or FLC2Av1 constructs,
from duplicate samples labeled on the same
day. (Right panel) Pooled data from three
experiments performed in duplicate showing
similar levels of surface-labeled anti-Hisalexa647
relative to EGFP autofluorescence for both FLC2A or FLC2Av1 constructs. To allow comparison between constructs transfected and labeled on the same day,
values derived from canonical C2A were normalized to one. Error bars are reported as the 95% confidence interval.
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